Brain4care key facts
as of Oct 2026- Developer of a non-invasive neurotechnology platform intended to monitor intracranial dynamics through cranial pulse analysis.
- Brain4care is valued at approximately $49.3M as of Oct 2026 (last reported valuation).
- It has raised $33.3M; the latest was Later Stage VC ($2.0M) in Dec 2025.
- Notable investors include GHT4 Group, Carlos Gutiérrez, Green Rock (Brazil), Horácio Lafer Piva, Miletus Ventures — 6 tracked in total.
- Status: Privately Held (backing).
Brain4care's last reported valuation, Jun 2023. Nothing priced has surfaced since.
- ·Watch Brain4care: the Monday email on marks, rounds and moves
Brain4care funding rounds
No funding rounds for Brain4care are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Brain4care valuation
Brain4care's last reported valuation was $49.3 million in Jun 2023. No priced round, secondary trade or fund mark has surfaced since.
Brain4care investors
6 investors are on record for Brain4care, including GHT4 Group, Carlos Gutiérrez, Green Rock (Brazil) and Horácio Lafer Piva.
About Brain4care
Developer of a non-invasive neurotechnology platform intended to monitor intracranial dynamics through cranial pulse analysis. The company offers an AI (artificial intelligence)-powered system for assessing brain compliance, pressure, perfusion, and autoregulation without invasive procedures, enabling healthcare providers to detect neurological deterioration earlier and improve patient monitoring outcomes.
- Sector
- Healthcare
- HQ
- Sao Carlos, Brazil
- Founded
- 2014
- Employees
- 40
- Website
- brain4.care/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.